The Design and Cell-Free Protein Synthesis of a Pembrolizumab Single-Chain Variable Fragment

Background/Objectives: Cancer is a leading cause of death. However, recently developed immunotherapies have shown significant promise to improve cancer treatment outcomes and survival rates. Pembrolizumab, a cancer immunotherapy drug, enables a strong T-cell response specifically targeting cancer ce...

Full description

Saved in:
Bibliographic Details
Main Authors: Landon E. Ebbert, Tyler J. Free, Mehran Soltani, Bradley C. Bundy
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Drugs and Drug Candidates
Subjects:
Online Access:https://www.mdpi.com/2813-2998/4/1/3
Tags: Add Tag
No Tags, Be the first to tag this record!